Keith B.
Keith B. Chellis, Kirkland, WA US
Patent application number | Description | Published |
---|---|---|
20140223377 | AutoSave and Manual Save Modes for Software Applications - Autosave and manual save modes in an application user interface on a computing device are provided. The computing device may be utilized to display a menu for receiving a selection of a menu option from the application user interface. The application user interface may display an electronic document to be saved. The menu option may include an option for switching between an autosave mode and a manual save mode for saving the electronic document. A selection of the menu option may then be received by the computing device. The computing device may then be utilized to activate one or more unique features associated with either the autosave mode or the manual save mode, based on the selected menu option, from the application user interface. | 08-07-2014 |
Keith B. Elkon, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20090325196 | LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS - The present invention provides a method of measuring the levels of BCMA in a biological sample, specifically upon the B cell surface. The diagnostic assays are useful in predicting an individual's likelihood of developing or currently suffering from an autoimmune disease, such as SLE, and for methods for treating an individual clinically diagnosed with an autoimmune disease. This diagnostic test serves to predict a patient's likelihood to respond to a specific drug treatment, in particular treatment with BLyS antagonists, either singly or in combination with other immune suppressive drugs | 12-31-2009 |
20140220014 | LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS - The present invention provides a method of measuring the levels of BCMA in a biological sample, specifically upon the B cell surface. The diagnostic assays are useful in predicting an individual's likelihood of developing or currently suffering from an autoimmune disease, such as SLE, and for methods for treating an individual clinically diagnosed with an autoimmune disease. This diagnostic test serves to predict a patient's likelihood to respond to a specific drug treatment, in particular treatment with BLyS antagonists, either singly or in combination with other immune suppressive drugs | 08-07-2014 |
Keith B. Gammie, Markham CA
Patent application number | Description | Published |
---|---|---|
20100186060 | UPLINK SIGNALING FOR GLOBAL DECODER CONTROL - Uplink signaling for controlling a plurality of decoders at a remote site. An uplink has a control server for controlling a storage system of the decoders at the remote site. The control server of the uplink controls the storage system by injecting at least one global control stream multiplexed with a transport stream. The transport multiplexed with the global control stream is formed at the uplink for controlling the decoders simultaneously. | 07-22-2010 |
Keith B. Kosanovich, Mill Creek, WA US
Patent application number | Description | Published |
---|---|---|
20100314339 | EQUIPMENT RACK PANEL SYSTEM AND METHOD - An equipment rack panel system using one or more rack extension panels with optional raceway to interconnect equipment cables to service cables through connectors within the rack extension panel. The rack extension panel is either fastened to or integral with one of the posts of the equipment rack or otherwise adjacent to the equipment rack and extends away from the equipment rack so as not to occupy space within the equipment rack normally reserved for equipment. | 12-16-2010 |
Keith B. Maddern, Tucson, AZ US
Patent application number | Description | Published |
---|---|---|
20120321937 | BATTERY END CAP - An battery end cap is disclosed for limiting current flow of a battery. The battery end cap includes a cap terminal, the cap terminal comprising an external conductive surface and an internal conductive surface. The battery end cap further includes a pressure sensitive switch, wherein when the battery end cap is installed on a battery, the pressure sensitive switch is configured to bias the internal conductive surface of the cap terminal from being in electrical communication with an electrical source of the battery. Electrical communication between the cap terminal and the electrical source is created or maintained when a sufficient external pressure is applied to the battery end cap and electrical contact between the cap terminal and the internal electrical source is broken without the sufficient external pressure. | 12-20-2012 |
20140371411 | POLYMER COMPOSITION WITH SALIVA LABILE AVERSIVE AGENT - For a polymer composition, a polymerizable aversive agent is chemically coupled to a substrate element. The chemical coupling is labile to saliva. | 12-18-2014 |
Keith B. Neeves, Denver, CO US
Patent application number | Description | Published |
---|---|---|
20130230879 | OPTICAL ALIGNMENT DEFORMATION SPECTROSCOPY - A microfluidic system, device, and method are disclosed. The microfluidic system may include a first microfluidic channel and a second microfluidic channel, each of which are carrying one or more objects. There is an intersection between the first and second microfluidic channels where one or more objects from the first microfluidic channel impact one or more objects from the second microfluidic channel under hydrodynamic forces. The impact causes the objects to deform and the deformation of objects can be analyzed to determine properties of the object. | 09-05-2013 |
20140038214 | MICROFLUIDIC FLOW ASSAY AND METHODS OF USE - A microfluidic-based flow assay and methods of manufacturing the same are provided. Specifically, the microfluidic flow assay includes a substrate surface comprising lipid coated particles and microfluidic channels through which a blood product can flow. The lipid coated particles comprise functional molecules that can induce or inhibit the coagulation cascade. | 02-06-2014 |
Keith B. Neeves, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20100098767 | CONVECTION ENHANCED DELIVERY APPARATUS, METHOD, AND APPLICATION - An embodiment of the invention is directed to a microfabrπcated, silicon-based, Convection Enhanced Delivery (CED) device The device comprises a silicon shank portion, at least one individual parylene channel disposed along at least a part of an entire length of the shank, wherein the channel has one or more dimensioned fluid exit ports disposed at one or more respective locations of the channel and a fluid (drug) input opening The fluid input opening may be configured or adapted to be connected to a fluid reservoir and/or a pump and/or a meter and/or a valve or other suitable control device(s) or apparatus that supplies and/or delivers fluid (e g, a drug) to the microfabricated device The device may have multiple channels disposed side by side or in different surfaces of the device | 04-22-2010 |
20140371712 | CONVECTION ENHANCED DELIVERY APPARATUS, METHOD, AND APPLICATION - An embodiment of the invention is directed to a microfabricated, silicon-based, Convection Enhanced Delivery (CED) device. The device comprises a silicon shank portion, at least one individual parylene channel disposed along at least a part of an entire length of the shank, wherein the channel has one or more dimensioned fluid exit ports disposed at one or more respective locations of the channel and a fluid (drug) input opening. The fluid input opening may be configured or adapted to be connected to a fluid reservoir and/or a pump and/or a meter and/or a valve or other suitable control device(s) or apparatus that supplies and/or delivers fluid (e.g., a drug) to the microfabricated device. The device may have multiple channels disposed side by side or in different surfaces of the device. The device may be rigid, or flexible, in which case a flexible device can be attached to a bio-degradable support scaffold that provides sufficient structural rigidity for insertion of the device into the target tissue. In certain “functionalized” embodiments of the invention, the CED device is equipped with integrated electrodes and/or a sensor (e.g., glutamate) to detect and convey selective parametric information. Another embodiment of the invention is directed to a CED method for drugs and/or other agents. The method may comprise the delivery of enzymes or other materials to modify tissue permeability and improve drug diffusion. Another embodiment of the invention is directed to a method for making a device for CED of drugs. | 12-18-2014 |
Keith B. Nolop, Millburn, NJ US
Patent application number | Description | Published |
---|---|---|
20100022493 | USE OF MOMETASONE FUROATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASE - The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed. | 01-28-2010 |
20120134935 | USE OF MOMETASONE FUROATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASE - The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed. | 05-31-2012 |
Keith B. Nolop, Redwood City, CA US
Patent application number | Description | Published |
---|---|---|
20110200647 | PULMONARY DISEASE TREATMENT - The invention relates to treating chronic obstructive pulmonary disease, involving the administration by inhalation of mometasone furoate particles in daily doses where at least about 250 μg of the inhaled particles have sizes equal to or less than 6.5 μm. | 08-18-2011 |
Keith B. Oxner, Chesterfield, MA US
Patent application number | Description | Published |
---|---|---|
20090289451 | T-Nut Assembly For Sealing An Existing Connection In A Lined Conduit - A T-nut assembly for reinstating a sealed connection in a lined conduit is provided. The assembly includes a rigid T-nut having a hollow tubular region with an engagement surface at one end and a base with an opening therethrough at the other. The base has a larger diameter than the tubular region. The T-nut includes an integral shoulder around the tubular member at the base and has a larger diameter than the tubular region and less than the base. The outside of the shoulder has a wall extending above the shoulder to form an annular recess at the engagement end. A substantially rigid sealing washer is placed in the annular recess and a compressible gasket is placed on the base about the shoulder. | 11-26-2009 |
20120012217 | CURED IN PLACE LINER SYSTEM AND INSTALLATION METHODS - A cured in place liner system and associated connections and methods are disclosed. The cured in place pipe system forms a completely rehabilitated, stand-alone, fluid-tight flow path between upstream and downstream portions of an existing pipe system. The rehabilitated flow path is stand-alone in that the liner system does not rely on structure of the portion of the pipe system through which the liner system is installed to define the fluid-tight flow path. The flow path between upstream and downstream portions of the liner system is defined by and made fluid-tight solely by components of the rehabilitation system such as cured in place liners and couplers. The portion of the pipe system through which the rehabilitation system is installed merely provides a path (e.g., through the ground) through which the cured in place liner system can be inserted. After the cured in place liner system is installed, the liner system forms a fluid-tight flow path between an upstream portion of the pipe system and a downstream portion of the pipe system. Various types of connections may be used. In addition, various types of methods may be used in forming the connections, such as using a mold to cure connecting sections of the cured in place liners in desired configurations (e.g., having a generally circular outer profile) for forming connections with the liners. | 01-19-2012 |
Keith B. Wilson, San Ramon, CA US
Patent application number | Description | Published |
---|---|---|
20100236481 | Preparation of Membranes Using Solvent-Less Vapor Deposition Followed by In-Situ Polymerization - A system of fabricating a composite membrane from a membrane substrate using solvent-less vapor deposition followed by in-situ polymerization. A first monomer and a second monomer are directed into a mixing chamber in a deposition chamber. The first monomer and the second monomer are mixed in the mixing chamber providing a mixed first monomer and second monomer. The mixed first monomer and second monomer are solvent-less vapor deposited onto the membrane substrate in the deposition chamber. The membrane substrate and the mixed first monomer and second monomer are heated to produce in-situ polymerization and provide the composite membrane. | 09-23-2010 |